…
Cheelcare Inc. develops, manufactures, and distributes assistive mobility devices. It offers robotic complex rehab power wheelchairs, power add-ons for manual wheelchairs, and wheelchair accessories. The company is based in Richmond Hill, Canada.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Public information on Cheelcare Inc. (CHER.V) is limited, and available sources do not clearly describe the company's core business. Long-term growth drivers are therefore uncertain; investors may find the stock attractive only if management clarifies strategy and demonstrates sustainable revenue or scalable operations.
Material risks include limited disclosure, low liquidity, potential need for additional financing, execution and governance risk, and regulatory uncertainty; investors should monitor filings and management updates.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-04-30 | 2024-04-30 | 2023-04-30 |
|---|---|---|---|
| Type | yearly | yearly | yearly |
| Date | 2025-04-30 | 2024-04-30 | 2023-04-30 |
| Income before tax | -1.27M | -0.54M | -0.13M |
| Net income | -1.27M | -0.54M | -0.13M |
| Selling general administrative | 0.07M | 0.72M | 0.37M |
| Gross profit | 0.80M | 0.77M | 0.58M |
| Reconciled depreciation | 0.05M | 0.00M | 0.01M |
| Ebit | -1.33M | - | - |
| Operating income | -1.33M | -0.30M | 0.08M |
| Interest expense | 0.28M | 0.19M | 0.16M |
| Tax provision | 0.00M | - | - |
| Net interest income | -0.32M | -0.25M | -0.20M |
| Total revenue | 1.57M | 1.44M | 1.11M |
| Total operating expenses | 2.12M | 1.73M | 1.03M |
| Cost of revenue | 0.77M | 0.67M | 0.53M |
| Total other income expense net | 0.01M | 0.00M | - |
| Net income from continuing ops | -1.27M | -0.54M | -0.13M |
| Net income applicable to common shares | -1.27M | - | - |
| Breakdown | 2025-04-30 | 2024-04-30 | 2023-04-30 |
|---|---|---|---|
| Type | yearly | yearly | yearly |
| Date | 2025-04-30 | 2024-04-30 | 2023-04-30 |
| Total assets | 4.17M | 0.60M | 0.38M |
| Intangible assets | 0.02M | 0.02M | 0.02M |
| Total liab | 7.33M | 2.95M | 2.27M |
| Total stockholder equity | 0.07M | -2.36M | -1.89M |
| Other current liab | 3.60M | - | - |
| Common stock | 0.26M | - | - |
| Capital stock | 0.49M | 0.49M | 0.49M |
| Retained earnings | -0.19M | -3.06M | -2.52M |
| Cash | 0.03M | 0.07M | 0.04M |
| Total current liabilities | 0.04M | 1.13M | 0.56M |
| Net debt | 2.06M | 1.46M | 1.07M |
| Short term debt | 0.00M | - | - |
| Short long term debt | 1.62M | 0.18M | 0.09M |
| Total current assets | 4.09M | 0.57M | 0.35M |
| Net receivables | 0.14M | 0.13M | 0.08M |
| Long term debt | 0.49M | 1.35M | 1.02M |
| Inventory | 0.29M | 0.33M | 0.20M |
| Accounts payable | 0.89M | 0.48M | 0.16M |
| Non current assets total | 0.08M | 0.03M | 0.03M |
| Long term debt total | 0.00M | - | - |
| Breakdown | 2025-04-30 | 2024-04-30 | 2023-04-30 |
|---|---|---|---|
| Type | yearly | yearly | yearly |
| Date | 2025-04-30 | 2024-04-30 | 2023-04-30 |
| Investments | - | -0.00M | 0.00M |
| Total cashflows from investing activities | -0.01M | - | - |
| Net borrowings | 0.67M | - | - |
| Total cash from financing activities | 4.00M | 0.24M | 0.05M |
| Net income | -0.07M | -0.54M | -0.13M |
| Change in cash | -0.12M | 0.03M | 0.02M |
| Begin period cash flow | 0.07M | 0.04M | 0.02M |
| End period cash flow | 3.56M | 0.07M | 0.04M |
| Total cash from operating activities | -0.50M | -0.21M | -0.03M |
| Depreciation | 0.05M | 0.00M | 0.01M |
| Other cashflows from investing activities | -0.07M | - | - |
| Change to inventory | -0.03M | -0.13M | 0.01M |
| Capital expenditures | 0.01M | 0.00M | 0.00M |
| Change in working capital | 0.33M | 0.28M | 0.03M |
| Stock based compensation | 0.33M | 0.00M | 0.00M |
| Other non cash items | 0.07M | 0.04M | 0.06M |
| Free cash flow | -0.51M | -0.21M | -0.03M |
Sector: Healthcare Industry: Medical Devices
|
Stock Name
|
Change
(CAD) |
Price
(CAD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
|---|---|---|---|---|---|---|---|
| CHER Cheelcare Inc. |
- -% |
1.25 | - | - | 20.92 | 106.42 | 21.26 |
| TLT Theralase Technologies Inc. |
0.01 5.56% |
0.19 | - | - | 90.07 | 82.51 | 90.31 |
| CNVI Conavi Medical Corp. |
-0.01 4.35% |
0.11 | - | - | 66.65 | - | 95.30 |
| PINK Perimeter Medical Imaging AI Inc |
-0.01 5.56% |
0.17 | 4.13 | - | 18.78 | 11.34 | 20.22 |
| ASG Aurora Spine Corp |
0.01 15.00% |
0.12 | - | - | 1.19 | 4.07 | 1.02 |
Cheelcare Inc. develops, manufactures, and distributes assistive mobility devices. It offers robotic complex rehab power wheelchairs, power add-ons for manual wheelchairs, and wheelchair accessories. The company is based in Richmond Hill, Canada.
| Name | Title | Year Born |
|---|---|---|
| Mr. Eugene Cherny | Founder & CEO, Director | NA |
| Mr. Dima Paltsev | Founder & CFO, Director, corporate secretary | NA |
| Mr. Allex Laurin | Director of Marketing | NA |
| Mr. Gennadiy Lisnyak | Chief Mechanical Engineer | NA |
| Mr. Yevgeny Cherny | Founder & CEO, Director | NA |
| Mr. Dmitry Paltsev | Founder & CFO, Director, corporate secretary | NA |
| Mr. Dmitry Paltsev | Founder, Director & Corporate Secretary | NA |
| Ms. Natasha Tsai C.A., CPA | Chief Financial Officer | 1981 |
| Dmitry Marukh | Director of Research & Development | NA |
| Allan Boyd | Vice President of Growth | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.